MOSCOW: Russia expects to register a second potential vaccine against coronavirus COVID-19 by October 15, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Tuesday (September 22).

The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.

Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials, involving at least 40,000 people, are ongoing.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here